HYDROxychloroquine in Syndrome Primary AntiPhospholipid

NCT04275778 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped The study was terminated following revisions to the diagnostic criteria defining the target pathology, which significantly impacted the study design

Conditions

Interventions

Sponsor

Assistance Publique - Hôpitaux de Paris